Shares of Udg Healthcare PLC (LON:UDG) have been assigned an average recommendation of “Buy” from the eight brokerages that are covering the firm. Two research analysts have rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average 12 month target price among brokers that have issued a report on the stock in the last year is GBX 689.17 ($8.61).

Several equities analysts recently issued reports on the company. Liberum Capital assumed coverage on Udg Healthcare PLC in a report on Thursday, October 27th. They issued a “buy” rating and a GBX 750 ($9.37) price target on the stock. Numis Securities Ltd reiterated an “add” rating and issued a GBX 730 ($9.12) price target on shares of Udg Healthcare PLC in a report on Monday, October 24th. Davy Research reiterated an “outperform” rating on shares of Udg Healthcare PLC in a report on Monday, October 24th. Berenberg Bank raised their price target on Udg Healthcare PLC from GBX 655 ($8.18) to GBX 700 ($8.75) and gave the company a “buy” rating in a report on Friday, October 7th. Finally, Jefferies Group raised their price target on Udg Healthcare PLC from GBX 680 ($8.50) to GBX 720 ($9.00) and gave the company a “buy” rating in a report on Friday, September 30th.

Udg Healthcare PLC (LON:UDG) opened at 645.50 on Thursday. Udg Healthcare PLC has a one year low of GBX 491.30 and a one year high of GBX 692.50. The firm’s market cap is GBX 1.59 billion. The stock has a 50 day moving average price of GBX 650.81 and a 200-day moving average price of GBX 613.20.

In other Udg Healthcare PLC news, insider Chris Corbin sold 90,849 shares of the firm’s stock in a transaction dated Monday, September 26th. The stock was sold at an average price of GBX 634 ($7.92), for a total transaction of £575,982.66 ($719,618.52).

About Udg Healthcare PLC

UDG Healthcare plc, formerly United Drug plc, is a healthcare services provider in the Republic of Ireland, the United Kingdom, North America and Continental Europe. The Company operates in three segments. The Ashfield Commercial & Medical Services segment is engaged in the provision of sales, marketing and healthcare communications services to pharmaceutical companies, and it also provides sales teams, healthcare communications, telesales, nurse educators, medical information, pharmacovigilance, regulatory and event management services to over 300 healthcare companies in approximately 20 countries.

Receive News & Stock Ratings for Udg Healthcare PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Udg Healthcare PLC and related stocks with our FREE daily email newsletter.